These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 4015285)

  • 41. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
    Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the antihypertensive effects of indapamide and metoprolol.
    Kubik MM; Coote JH
    Postgrad Med J; 1981; 57 Suppl 2():44-50. PubMed ID: 7033946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.
    Hoffmann J
    Blood Press Suppl; 1993; 1():30-6. PubMed ID: 8173688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Protection of the hypertensive patient: comparative study of atenolol and metoprolol].
    Mazzari M; Coppola E; Montenero AS; Schiavoni G; Domenichelli B; Mongiardo R; Pennestrì F
    Cardiologia; 1982; 27(8):753-63. PubMed ID: 6765444
    [No Abstract]   [Full Text] [Related]  

  • 46. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
    Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM; MacDonald TM; Prasad N; Maclean D; Peebles L; McDevitt DG
    QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study of oxprenolol and atenolol in the treatment of hypertension.
    Kamili MA; Allaqaband GQ; Ali G; Shah MY; Sheikh AS
    Indian Heart J; 1988; 40(6):471-4. PubMed ID: 3248806
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
    O'Brien KP; Stephens EJ
    N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.
    Traub YM
    Arch Intern Med; 1988 Jan; 148(1):77-80. PubMed ID: 3276279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative study of atenolol and metoprolol in the treatment of hypertension.
    Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
    Br J Clin Pharmacol; 1981 Dec; 12(6):887-91. PubMed ID: 7340890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular responses to verapamil and propranolol in hypertensive patients.
    McInnes GT; Findlay IN; Murray G; Cleland JG; Dargie HJ
    J Hypertens Suppl; 1985 Dec; 3(3):S219-21. PubMed ID: 2856708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
    Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
    Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
    [No Abstract]   [Full Text] [Related]  

  • 54. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Once daily administration of a beta-blocker in hypertension.
    Watt M; Duncan TD
    N Z Med J; 1978 Feb; 87(606):126-8. PubMed ID: 274648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antihypertensive effect and adverse effects of treatment with beta-blocking agents].
    Andersson O; Berglund G; Bergman H; Cramér K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Lakartidningen; 1975 Nov; 72(48):4738-40. PubMed ID: 1105030
    [No Abstract]   [Full Text] [Related]  

  • 58. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
    Chen MF; Yang CY; Chen WJ; Lee CM; Wu CC; Liau CS; Lee YT
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
    Epstein SE; LUbbe WF
    S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The fixed combination of propranolol and bendrofluazide in the treatment of hypertension.
    Jäättelä A
    Ann Clin Res; 1979 Apr; 11(2):80-2. PubMed ID: 378094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.